FDA Moves To Implement New GMP Policies

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-02-2004
Volume 28
Issue 11

Phase II of FDA's GMP modernization plan may involve revising regulations to fit new policies and inspection and review programs.

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development